The primary goal of the recently renamed Functional Genomics and Microbiome Core (Core C) is to enhance research programs in infection and injury states affecting the mammalian intestine and liver by providing genomics and metagenomics expertise and resources. In this Core, we utilize advanced technology in mammalian and microbial genomics to support ongoing and innovative research to prevent and cure digestive diseases. This Core enables investigators to posit research questions related to gene expression, functional genomics and molecular mechanisms by utilizing the tools of microarrays, deep nucleic acid sequencing (microbial and mammalian), nucleic acid amplification, protein profiling, and bioinformatics. PCR based analyses of gene expression and splicing, DNA mutation/SNP detection, and gene pathway analyses ofthe mammalian metagenome (microbe and man) will be fostered by this Core as a platform for gastrointestinal and hepatic systems biology. Our mission is to provide a full service resource from experimental design to consultations about specimen processing, robust data analysis pipelines, and biostatistical support. In summary, we have created a fully integrated genomic analysis platform for investigators studying digestive diseases.

Public Health Relevance

This Core provides help with complex molecular technologies such as gene expression profiling and genomic microarray analyses, complex protein bead assays, metagenomic sequencing and microbiome analyses needed by DDC members.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK056338-15
Application #
9242619
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2001-04-15
Project End
2018-04-30
Budget Start
2017-03-01
Budget End
2018-02-28
Support Year
15
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Kulik, Laura; El-Serag, Hashem B (2018) Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology :
Mindikoglu, Ayse L; Pappas, Stephen C (2018) New Developments in Hepatorenal Syndrome. Clin Gastroenterol Hepatol 16:162-177.e1
Barbour, Linda A; Scifres, Christina; Valent, Amy M et al. (2018) A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol 219:367.e1-367.e7
Zaheer, Mahira; Wang, Changjun; Bian, Fang et al. (2018) Protective role of commensal bacteria in Sjögren Syndrome. J Autoimmun 93:45-56
Koh, Eun-Hee; Chernis, Natasha; Saha, Pradip K et al. (2018) miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in Obesity. Diabetes 67:2541-2553
Ganesh, Bhanu Priya; Fultz, Robert; Ayyaswamy, Sriram et al. (2018) Microbial interactions with the intestinal epithelium and beyond: Focusing on immune cell maturation and homeostasis. Curr Pathobiol Rep 6:47-54
Kruse, Robert L; Shum, Thomas; Tashiro, Haruko et al. (2018) HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice. Cytotherapy 20:697-705
Criglar, Jeanette M; Anish, Ramakrishnan; Hu, Liya et al. (2018) Phosphorylation cascade regulates the formation and maturation of rotaviral replication factories. Proc Natl Acad Sci U S A 115:E12015-E12023
Bethea, Emily D; Samur, Sumeyye; Kanwal, Fasiha et al. (2018) Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy. Clin Gastroenterol Hepatol :
Balakrishnan, Maya; George, Rollin; Sharma, Ashish et al. (2018) An Investigation into the Recent Increase in Gastric Cancer in the USA. Dig Dis Sci 63:1613-1619

Showing the most recent 10 out of 1121 publications